AQST Aquestive Therapeutics, Inc.

NASDAQ
$4.68

Aquestive Therapeutics, Inc. (AQST) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +9.6% since its last earnings release on August 11, 2026.

Aquestive Therapeutics Missed Consensus Estimates, Reaffirms Below Estimates
Tuesday, August 11, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:00 PM ET
Earnings Whisper
-
vs ($0.10)
Rev est $11.03M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.74

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Aquestive Therapeutics, Inc.

Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients.

Sector

Healthcare

Industry

Drug Delivery

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.